OSSDSIGN AB |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 9.54 SEK | -.--% |
|
-1.65% | +19.25% |
| 14/05 | Transcript : OssDsign AB, Q1 2024 Earnings Call, May 14, 2024 | |
| 14/05 | OssDsign AB Reports Earnings Results for the First Quarter Ended March 31, 2024 | CI |
Presenter SpeechKristofer Berggren (Attendees)Hello, and welcome to this Q4 presentation with ...
This article is reserved for subscribers
Signed up already?
Log InNot subscribed yet?
Subscribe
OssDsign AB, formerly known as Oss-Q AB is a Sweden-based orthopedic medical device company. It aims at developing implantable products that respond to clinical challenges, with focus on bone healing. Its primary focus is skull surgery. The Company uses design solutions, material compositions and manufacturing processes mainly based on proprietary bioceramic technologies. The bioceramics it uses integrate with tissues and support bone ingrowth. OssDsign AB's main product is Craniomosaic, an implant for the repair of skull defects (cranioplasty). Along with it, the Company develops bioceramic implants for facial bone augmentation. The Company's customers include neurosurgeons, craniofacial and maxillofacial surgeons.
Calendar
25/06/2024
- Annual General Meeting
Trading Rating
Investor Rating
ESG Refinitiv
EPS Revisions
| 1st Jan change | Capi. | |
|---|---|---|
| +19.25% | 87.98M | |
| +13.73% | 130B | |
| -8.17% | 10.97B | |
| -4.33% | 8.42B | |
| +41.80% | 5.57B | |
| -21.94% | 4.59B | |
| +7.81% | 3.42B | |
| -10.26% | 2.73B | |
| -10.29% | 2.08B | |
| -13.58% | 1.92B |
- Stock Market
- Equities
- OSSD Stock
- News OssDsign AB
- Transcript : OssDsign AB, Q4 2021 Earnings Call, Feb 22, 2022
